Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-001291

EXEC. VP AND CLO sold 3,541 shares at an average $44.87 ($158,871)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Boulding Mark Elliott · EXEC. VP AND CLO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-07 Sale : show line 1 in the form 10b5-1 −1,543 $45.34 $69,960 108,846 D
2025-01-08 Sale : show line 2 in the form 10b5-1 −1,998 $44.50 $88,911 106,848 D
Open-market sales · 3,541 sh · avg $44.87 · $158,871
Loading xslF345X05/form4-01102025_050103.xml…